Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.770
-0.020 (-0.53%)
Feb 21, 2025, 4:00 PM EST - Market closed
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 43 employees as of December 31, 2021. The number of employees increased by 21 or 95.45% compared to the previous year.
Employees
43
Change (1Y)
21
Growth (1Y)
95.45%
Revenue / Employee
$60,488
Profits / Employee
-$1,425,023
Market Cap
91.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ARTV News
- 1 day ago - Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 23 days ago - Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D. - GlobeNewsWire
- 3 months ago - Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference - GlobeNewsWire
- 4 months ago - Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors - GlobeNewsWire
- 5 months ago - Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 6 months ago - Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch - Benzinga